| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.3 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |